HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dipti V Tillu Selected Research

Cytokines

11/2010IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dipti V Tillu Research Topics

Disease

8Pain (Aches)
11/2021 - 11/2010
5Chronic Pain
09/2015 - 01/2012
4Hypersensitivity (Allergy)
01/2017 - 07/2014
3Hyperalgesia
01/2012 - 05/2011
2Postoperative Pain
01/2019 - 01/2017
2Neuralgia (Stump Neuralgia)
01/2019 - 09/2011
1Neoplasms (Cancer)
05/2015
1Surgical Wound
01/2012
1Peripheral Nerve Injuries
09/2011

Drug/Important Bio-Agent (IBA)

4Interleukin-6 (Interleukin 6)IBA
07/2014 - 11/2010
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 03/2013
3Dinoprostone (PGE2)FDA Link
05/2015 - 01/2012
3Eukaryotic Initiation Factor-4F (EIF4F)IBA
05/2015 - 11/2010
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2021 - 07/2017
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2021 - 07/2017
2Metformin (Glucophage)FDA LinkGeneric
01/2017 - 09/2011
2ResveratrolIBA
01/2017 - 01/2012
2Peptide Initiation Factors (Initiation Factor)IBA
05/2015 - 11/2010
2Phosphotransferases (Kinase)IBA
05/2015 - 03/2013
2Proteins (Proteins, Gene)FDA Link
05/2015 - 09/2011
2AMP-Activated Protein KinasesIBA
01/2012 - 09/2011
1Fibronectins (Fibronectin)IBA
07/2017
1Tyrosine (L-Tyrosine)FDA Link
07/2017
1EphrinsIBA
07/2017
1Analgesics (Analgesic Drugs)IBA
01/2017
1Opioid Analgesics (Opioids)IBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
09/2015
1PAR-2 ReceptorIBA
05/2015
1Proteinase-Activated ReceptorsIBA
05/2015
1U 0126 (UO 126)IBA
05/2015
1PKC-3 proteinIBA
05/2015
1TropomyosinIBA
05/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2015
1Dopamine (Intropin)FDA LinkGeneric
04/2015
1CarrageenanIBA
04/2015
1AnisomycinIBA
04/2015
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
04/2015
1Dyneins (Dynein)IBA
07/2014
1DNA (Deoxyribonucleic Acid)IBA
07/2014
1Protein Synthesis InhibitorsIBA
07/2014
1OligonucleotidesIBA
07/2014
1Sodium Channels (Sodium Channel)IBA
09/2011
14- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA
09/2011
1Protein Kinases (Protein Kinase)IBA
09/2011
1Adenosine Monophosphate (AMP)IBA
09/2011
1PeptidomimeticsIBA
05/2011
1metabotropic glutamate receptor type 1IBA
05/2011
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
05/2011
1Prostaglandins EIBA
05/2011
1ProstaglandinsIBA
05/2011
13,4-dihydroxyphenylglycolIBA
05/2011
1Nerve Growth Factors (Neurotrophins)IBA
11/2010
1Nerve Growth Factor (NGF)IBA
11/2010
1CytokinesIBA
11/2010

Therapy/Procedure

3Therapeutics
01/2017 - 09/2011
2Spinal Injections
07/2014 - 05/2011
1Topical Administration
01/2017